ChangE From Any Systemic psoriasiS therapY to Raptiva
Status:
Terminated
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
To assess the safety of transitioning subjects to Raptiva therapy from standard oral systemic
or phototherapy by overlapping with Raptiva whilst tapering the initial systemic therapy or
phototherapy dose.